Drugs / HRG2005
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06035393 | Jan 2024 → Feb 2025 | chronic obstructive pulmonary disease | Jiangsu HengRui Medicine Co., Ltd. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HRG2005 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06035393 ↗ |
| Route | Inhaled | “HRG2005 inhalation” NCT06035393 ↗ |